These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19631535)

  • 21. Total synthesis of ezetimibe, a cholesterol absorption inhibitor.
    Śnieżek M; Stecko S; Panfil I; Furman B; Chmielewski M
    J Org Chem; 2013 Jul; 78(14):7048-57. PubMed ID: 23763523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of C3 heteroatom-substituted azetidinones that display potent cholesterol absorption inhibitory activity.
    McKittrick BA; Ma K; Huie K; Yumibe N; Davis H; Clader JW; Czarniecki M; McPhail AT
    J Med Chem; 1998 Feb; 41(5):752-9. PubMed ID: 9513603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake.
    Yu L; Bharadwaj S; Brown JM; Ma Y; Du W; Davis MA; Michaely P; Liu P; Willingham MC; Rudel LL
    J Biol Chem; 2006 Mar; 281(10):6616-24. PubMed ID: 16407187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of iodinated biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors.
    Burnett DA; Caplen MA; Domalski MS; Browne ME; Davis HR; Clader JW
    Bioorg Med Chem Lett; 2002 Feb; 12(3):311-4. PubMed ID: 11814785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An enzymatic synthesis of glucuronides of azetidinone-based cholesterol absorption inhibitors.
    Reiss P; Burnett DA; Zaks A
    Bioorg Med Chem; 1999 Oct; 7(10):2199-202. PubMed ID: 10579526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe.
    Sancheti PP; Karekar P; Vyas VM; Shah M; Pore YV
    Pharmazie; 2009 Apr; 64(4):227-31. PubMed ID: 19435139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterocyclic ring scaffolds as small-molecule cholesterol absorption inhibitors.
    Ritter T; Kvaernø L; Werder M; Hauser H; Carreira EM
    Org Biomol Chem; 2005 Oct; 3(19):3514-23. PubMed ID: 16172689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sugar-substituted 2-azetidinone cholesterol absorption inhibitors: enhanced potency by modification of the sugar.
    Vaccaro WD; Davis HR
    Bioorg Med Chem Lett; 1998 Feb; 8(3):313-8. PubMed ID: 9871676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Davis HR; Murgolo NJ; Graziano MP
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677799
    [No Abstract]   [Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of some 2-azetidinone derivatives as potential antihyperlipidemic agents.
    Arya N; Dwivedi J; Khedkar VM; Coutinho EC; Jain KS
    Arch Pharm (Weinheim); 2013 Dec; 346(12):872-81. PubMed ID: 24142910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem Lett; 1998 Jan; 8(1):35-40. PubMed ID: 9871624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorption.
    Pfefferkorn JA; Larsen SD; Van Huis C; Sorenson R; Barton T; Winters T; Auerbach B; Wu C; Wolfram TJ; Cai H; Welch K; Esmaiel N; Davis J; Bousley R; Olsen K; Mueller SB; Mertz T
    Bioorg Med Chem Lett; 2008 Jan; 18(2):546-53. PubMed ID: 18063367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Azetidinone cholesterol absorption inhibitors: increased potency by substitution of the C-4 phenyl ring.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem; 1998 Sep; 6(9):1429-37. PubMed ID: 9801814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creation of intercellular bonds by anchoring protein ligands to membranes using the diphtheria toxin T domain.
    Perier A; Gourier C; Pichard S; Husson J; Lajeunesse E; Babon A; Menez A; Gillet D
    FEBS Lett; 2007 Nov; 581(28):5480-4. PubMed ID: 17991440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoothened antagonists for hair inhibition.
    Li JJ; Shanmugasundaram V; Reddy S; Fleischer LL; Wang Z; Smith Y; Harter WG; Yue WS; Swaroop M; Li L; Ji CX; Dettling D; Osak B; Fitzgerald LR; Conradi R
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4932-5. PubMed ID: 20620058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate sulfonyl chlorides for simple, convenient access to glycoconjugates.
    Kvaernø L; Werder M; Hauser H; Carreira EM
    Org Lett; 2005 Mar; 7(6):1145-8. PubMed ID: 15760160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas.
    Hart T; Macias AT; Benwell K; Brooks T; D'Alessandro J; Dokurno P; Francis G; Gibbons B; Haymes T; Kennett G; Lightowler S; Mansell H; Matassova N; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Walls S; Wong M; Roughley S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4241-4. PubMed ID: 19515560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of ezetimibe.
    Ashikaga H; Blumenthal RS; Jones SR
    Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
    [No Abstract]   [Full Text] [Related]  

  • 39. Preparation of conophylline affinity nano-beads and identification of a target protein.
    Suzuki E; Ogura H; Kato K; Takei I; Kabe Y; Handa H; Umezawa K
    Bioorg Med Chem; 2009 Sep; 17(17):6188-95. PubMed ID: 19679484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-Azetidinone derivatives: design, synthesis and evaluation of cholesterol absorption inhibitors.
    Wang Y; Zhang H; Huang W; Kong J; Zhou J; Zhang B
    Eur J Med Chem; 2009 Apr; 44(4):1638-43. PubMed ID: 18990470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.